a day ago
Cantor Fitzgerald Sticks to Its Buy Rating for Prenetics Group (PRE)
Cantor Fitzgerald analyst Ross Osborn maintained a Buy rating on Prenetics Group (PRE – Research Report) on June 12 and set a price target of $14.00. The company's shares closed last Friday at $7.01.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Osborn covers the Healthcare sector, focusing on stocks such as NeuroPace, Cerus, and Avita Medical. According to TipRanks, Osborn has an average return of -13.8% and a 24.68% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Prenetics Group with a $14.00 average price target.
The company has a one-year high of $11.99 and a one-year low of $3.09. Currently, Prenetics Group has an average volume of 24.86K.
